EP Patent

EP1023075B1 — Flüssige darreichungsformen oxazaphosphorinhaltiger pharmazeutischer produkte

Assigned to Stada Arzneimittel AG · Expires 2006-12-20 · 19y expired

What this patent protects

Patent listed against Cytoxan (Lyophilized).

Drugs covered by this patent

Cytoxan (Lyophilized) (cyclophosphamide) · Baxter

Patent Metadata

Patent number: EP1023075B1
Jurisdiction: EP
Classification: —
Expires: 2006-12-20
Drug substance claim: No
Drug product claim: No
Assignee: Stada Arzneimittel AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.